This Diagnostics Company Is Advancing a Global Expansion Strategy, Positioning for Growth Phase [Globe and Mail, The (Toronto, Canada)]
Co-Diagnostics, Inc. (CODX)
US:NASDAQ Investor Relations:
ir.codiagnostics.com/investor-relations
Company Research
Source: Globe and Mail, The
testing, global distribution networks, and next-generation platforms powered by artificial intelligence. As regulatory pathways reopen and international markets expand, companies with scalable, adaptable technologies are working to reposition themselves for long-term growth. Shares of Co-Diagnostics, Inc. ( NASDAQ: CODX ) finished Tuesday higher after the company reported its full-year 2025 financial results and outlined progress across its global commercialization strategy, clinical pipeline, and technology development initiatives. For the full year, Co-Diagnostics reported revenue of $0.6 million, down from $3.9 million in 2024, primarily reflecting a decline in grant revenue. Operating expenses totaled $50.6 million, including a non-cash impairment charge of $18.9 million related to intangible assets. The company reported a net loss of $46.9 million, while adjusted EBITDA loss improved to $28.0 million compared to $33.5 million in the prior year. Beyond the financials, manage
Show less
Read more
Impact Snapshot
Event Time:
CODX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CODX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CODX alerts
High impacting Co-Diagnostics, Inc. news events
Weekly update
A roundup of the hottest topics
CODX
News
- Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City [TheStreet.com]TheStreet.com
- Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial CityPR Newswire
- Co-Diagnostics anticipates India TB test commercialization by Q3 '26 while exploring CoSara SPAC options [Seeking Alpha]Seeking Alpha
- Co-Diagnostics, Inc. (CODX) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Co-Diagnostics Inc (CODX) Q4 2025 Earnings Call Highlights: Strategic Expansions and Financial ... [Yahoo! Finance]Yahoo! Finance
CODX
Earnings
- 3/31/26 - Miss
CODX
Sec Filings
- 3/31/26 - Form 10-K
- 3/31/26 - Form 8-K
- 3/10/26 - Form 8-K
- CODX's page on the SEC website